Showing results (21-30 of 504) with videos related to
Sort By:
Pageof 51
Digestion|December 14, 2011
Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective studySoo Ki Kim, Hiroyuki Marusawa, Yuji Eso, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2012
Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantationYoshihide Ueda, Hiroyuki Marusawa, Toshimi Kaido, et al.Internal Medicine (Tokyo, Japan)|April 8, 2010
Spontaneous rupture of liver plasmacytoma mimicking hepatocellular carcinomaKosuke Ueda, Hiroyuki Matsui, Tomohiro Watanabe, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|September 4, 2004
[GERD. Introduction]Tsutomu ChibaNihon Rinsho. Japanese Journal of Clinical Medicine|March 25, 2004
[Future for basic and clinical studies on peptic ulcer disease]Tsutomu ChibaJournal of Gastroenterology|November 23, 2011
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center studyYukio Osaki, Yoshihide Ueda, Hiroyuki Marusawa, et al.Transplantation|September 4, 2015
Interferon-Free Therapy for Hepatitis C in Liver Transplant RecipientsYoshihide Ueda, Shinji UemotoBiochemical and Biophysical Research Communications|January 24, 2006
Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytesYuichi Tanaka, Hiroyuki Marusawa, Hiroshi Seno, et al.Transplantation|October 26, 2013
Chronic rejection associated with antiviral therapy for recurrent hepatitis C after living-donor liver transplantationYoshihide Ueda, Toshimi Kaido, Takashi Ito, et al.Plos One|October 4, 2011
Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencingAkihiro Nasu, Hiroyuki Marusawa, Yoshihide Ueda, et al.Pageof 51